SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories informs about press release

21 May 2021 Evaluate

Morepen Laboratories has informed that it has enclosed a press release on 21st May 2021 titled ‘Morepen EGM approves Rs 433 Crore incoming investment from Corinth and promoters.’

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

59.44 -0.27 (-0.45%)
03-Jul-2026 14:29 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1905.85
Dr. Reddys Labs. 1373.65
Cipla 1458.00
Zydus Lifesciences 1134.50
Lupin 2468.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: